

Cover Story
Many people love the 340B Drug Pricing Program.
By Tessa Vellek
By Tessa Vellek
In Brief


Trending Stories
- Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills - Fired NCI employee says Trump’s purge was baseless yet punitive
“I feel like I’ve been erased” - Biden’s FY23 proposal cuts NCI funds by $199M, while boosting ARPA-H by $4B
- Former CDER Director Patrizia Cavazzoni named Pfizer chief medical officer, executive vice president
- Biomarker-driven innovation: What the FDA’s evolving strategy means for oncology
- Pushing for tax cuts, Trump threatens the federal workforce, Medicaid, and cancer research